Table 5 Prosthetic-related complications and mortality of simultaneous and staged BTHA during entire follow-up period
Complication | Simultaneous BTHA (126 hips) | Staged BTHA (120 hips) | P value | ||
|---|---|---|---|---|---|
Overall incidence | Proportion of second hip given occurrence (n; %) | Overall incidence | Proportion of second hip given occurrence (n; %) | ||
Intraoperative fracture (n; %)a | 10 (8) | 3/10 (30) | 7 (6) | 5/7 (71) | 0.516† |
Dislocation (n; %)a | 0 (0) | 0/0 (0) | 0 (0) | 0/0 (0) | 1.000‡ |
Aseptic loosening (n; %)a | |||||
Acetabular component | 0 (0) | 0/0 (0) | 1 (1) | 1/1 (100) | 0.488‡ |
Femoral component | 2 (2) | 1/2 (50) | 1 (1) | 1/1 (100) | 1.000‡ |
Superficial or deep wound infection (n; %)a | 0 (0) | 0/0 (0) | 2 (2) | 2/2 (100) | 0.237‡ |
Periprosthetic fracture (n; %)a | 0 (0) | 0/0 (0) | 0 (0) | 0/0 (0) | 1.000‡ |
Revision surgery (n; %)a | 2 (2) | 1/2 (50) | 4 (3) | 4/4 (100) | 0.437‡ |
Mortality (n; %)b | |||||
6 weeks | 0 (0) | - | 0 (0) | - | 1.000‡ |
1 year | 1 (2) | - | 0 (0) | - | 1.000‡ |
2 year | 1 (2) | - | 1 (2) | - | 1.000‡ |